Combination of Anti-PD-1 Antibody and Chemotherapy in Pancreatic Cancer

Clinical trial NCT03983057 · COMPLETED

Trial details

NCT number: NCT03983057
Sponsor: Zhejiang University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2019-04-01
Primary completion: 2025-11-25
Enrollment: 392

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.